These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26860483)

  • 21. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
    Yang SM; You JF; Zhang XW; Zheng J; Liao SL
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p57KIP2 immunohistochemical expression: a useful diagnostic tool in discrimination between complete hydatidiform mole and its mimics.
    Sarmadi S; Izadi-Mood N; Abbasi A; Sanii S
    Arch Gynecol Obstet; 2011 Apr; 283(4):743-8. PubMed ID: 20361201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetraploid partial hydatidiform mole: a case report and review of the literature.
    Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM
    Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
    Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M
    Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
    Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT
    Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
    McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of P57KIP2 Immunohistochemical Expression in Histological Diagnosis of Hydatidiform Moles.
    Triratanachat S; Nakaporntham P; Tantbirojn P; Shuangshoti S; Lertkhachonsuk R
    Asian Pac J Cancer Prev; 2016; 17(4):2061-6. PubMed ID: 27221896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history of partial molar pregnancy.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1985 Nov; 66(5):677-81. PubMed ID: 2414703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent bilateral theca lutein cysts in association with normal pregnancy.
    al-Harbi O; al-Saleem A; al-Tayeb O; Giangreco AB
    Ultrasound Obstet Gynecol; 1998 Mar; 11(3):222-4. PubMed ID: 9589149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First trimester diagnosis of partial mole.
    Phupong V; Triratanachat S; Promchainant C; Ultchaswadi P
    Arch Gynecol Obstet; 2005 Sep; 272(3):235-7. PubMed ID: 15875207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydatidiform mole.
    Hubbard JL; Hosmer SB
    J Am Osteopath Assoc; 1997 May; 97(5):296-8. PubMed ID: 9195794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent gestational trophoblastic disease after an androgenetic/biparental fetal chimera: a case report and review.
    Surti U; Hoffner L; Kolthoff M; Dunn J; Hunt J; Sniezek L; Macpherson T
    Int J Gynecol Pathol; 2006 Oct; 25(4):366-72. PubMed ID: 16990714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes.
    Zainal N; Kampan NC; Rose IM; Ghazali R; Shafiee MN; Yussoff NH; Tamil A; Jamil MA; Hussin NH
    Horm Mol Biol Clin Investig; 2021 May; 42(3):311-316. PubMed ID: 34018382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of p57Kip2 and its significance in the classification and differential diagnosis of hydatidiform moles and hydropic abortions].
    He Y; Yang KX; Wang HJ; Xu L; Huang Q; Wu XL
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):197-9. PubMed ID: 17535690
    [No Abstract]   [Full Text] [Related]  

  • 36. Cervical hydatidiform molar pregnancy.
    Wee HY; Tay EH; Soong Y; Loh SF
    Aust N Z J Obstet Gynaecol; 2003 Dec; 43(6):473-4. PubMed ID: 14712955
    [No Abstract]   [Full Text] [Related]  

  • 37. Sonographic findings and clinical correlations in molar pregnancy.
    Santos-Ramos R; Forney JP; Schwarz BE
    Obstet Gynecol; 1980 Aug; 56(2):186-92. PubMed ID: 7393507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective uterine artery embolization: a new therapeutic approach in a patient with low-risk gestational trophoblastic disease.
    Carlini L; Villa A; Busci L; Trezzi G; Agazzi R; Frigerio L
    Am J Obstet Gynecol; 2006 Jul; 195(1):314-5. PubMed ID: 16813760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p57KIP2 immunostaining in the diagnosis of complete versus partial hydatidiform moles.
    Sebire NJ; Lindsay I
    Histopathology; 2006 Jun; 48(7):873-4. PubMed ID: 16722940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.